Zaher Koutoubi

Zaher Koutoubi

Auto-generated profile, based on publicly available information

Zaher Koutoubi

Department of Gastroenterology, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in ACG Case Reports Journal
Verified
Journal Article
Open access
HAHamdan AlAwadhi
Hamdan AlAwadhi
MAMuna Almutawa
Muna Almutawa
SOSara El Ouali
Sara El Ouali
ZKZaher Koutoubi
Zaher Koutoubi
EMEsat Memisoglu
Esat Memisoglu
RNRajaie Namas
Rajaie Namas
The coexistence of systemic lupus erythematosus (SLE) and Crohn disease (CD) is rare and presents significant diagnostic and therapeutic challenges due to overlapping clinical, radiologic, and histologic features. We present a 24-year-old woman with SLE, chronic immune thrombocytopenic purpura, and newly diagnosed CD treated with risankizumab, an interleukin-23 inhibitor approved for CD. She achieved complete clinical and radiologic remission of CD without SLE flares over 12 months. To the best of our knowledge, this represents the first documented case of risankizumab successfully used in a patient with SLE and CD. Further research is needed to assess the long-term safety and wider applicability of interleukin-23 inhibitors for this underserved patient population.